Pfizer COVID vaccine trial shows alarming evidence of pathogenic priming in older adults

In some cases, the vaccinated animals died.

This phenomenon, known as vaccine-enhanced disease (VED), has been observed in other coronaviruses and is a major concern for scientists developing vaccines against SARS-CoV-2, the virus that causes COVID-19. VED occurs when a vaccine stimulates an overly strong immune response that can cause more harm than good. This could lead to serious complications or even death in people who are vaccinated.

To prevent VED from occurring with SARS-CoV-2 vaccines, researchers are taking several precautions. First, they are using different types of vaccine platforms to reduce the risk of overstimulating the immune system. Second, they are testing potential vaccines on animals to ensure that they do not cause VED before moving on to human trials. Finally, researchers are closely monitoring participants in clinical trials for any signs of VED and adjusting their protocols accordingly.

Although there is still much work to be done before a safe and effective vaccine against SARS-CoV-2 is available, scientists remain hopeful that their efforts will pay off and help protect people from this deadly virus.

He explained that the RSV vaccine was never approved due to safety concerns, and that the same could be true for a coronavirus vaccine. He warned of potential side effects such as inflammation of the brain, which can lead to seizures and even death.

Dr. Hotez’s warning highlights the importance of taking a cautious approach when developing a coronavirus vaccine. Vaccine developers must ensure that any potential vaccine is safe and effective before it is released to the public. This means conducting rigorous clinical trials with large sample sizes and long-term follow-up studies to monitor for any adverse events or long-term effects. Additionally, regulators must carefully review all data from these trials before approving any new vaccines for use in humans.

He would likely go to a medical research center or hospital to register this phenomenon. He could also contact the Centers for Disease Control and Prevention (CDC) or other public health organizations to report his findings.

The enhanced immune response seen in the 1950s RSV vaccine tests was a major cause for concern, as it suggested that the vaccine could actually make the infection worse. This is why Hotez’s statement is so important; if there is evidence of immune enhancement in animals, then this could be a sign that the vaccine may not be safe for humans and should not be used.

This is why the virus can cause an autoimmune response.

The Vaccines and Related Biological Products Advisory Committee Briefing Document on the Pfizer-BioNTech COVID-19 vaccine does not provide a clear definition of what constitutes a serious adverse event. This lack of clarity can lead to underreporting of serious adverse events, as well as misclassification of milder events as serious. Furthermore, the document does not provide any guidance on how to distinguish between an adverse event that is caused by the vaccine and one that is unrelated. This lack of clarity can lead to false positives in safety signals, which could result in unnecessary alarm or even withdrawal of the vaccine from the market.

In addition, the document does not address long-term safety issues such as pathogenic priming or other delayed effects that may occur after vaccination. While short-term safety data are important for assessing immediate risks associated with a vaccine, it is also essential to consider potential long-term effects before making decisions about its use. Without this information, it is impossible to make informed decisions about whether or not a vaccine should be approved for use in humans.

Finally, the document fails to consider external costs associated with vaccines such as lost productivity due to illness or death resulting from vaccination. These costs are often overlooked when evaluating the safety and efficacy of vaccines but can have significant impacts on public health and economic outcomes if they are not taken into account.

Overall, while the Vaccines and Related Biological Products Advisory Committee Briefing Document on the Pfizer-BioNTech COVID-19 vaccine provides some useful information about short-term safety issues related to this particular vaccine, it fails to adequately address longer term safety concerns or external costs associated with its use. As such, further research is needed before any conclusions can be drawn about its overall safety profile and potential benefits for public health.

The second issue is the lack of long-term follow up in the study. The study only followed participants for two months after their second dose, which is not enough time to detect any long-term effects of the vaccine. Long-term follow up is essential to determine if there are any delayed or chronic adverse events that may occur as a result of the vaccine. Additionally, it is important to understand how long immunity lasts and if booster shots will be needed in order to maintain protection from COVID-19.

The third issue is the lack of data on pregnant women and children in the study. It is important to understand how safe and effective the vaccine is for these populations, as they are more vulnerable to serious complications from COVID-19. Furthermore, it is important to understand if there are any potential risks associated with vaccinating pregnant women or children that could outweigh any potential benefits.

The design and analysis set-up of the study are biased against finding adverse events because the study is designed to measure the effectiveness of a drug, not its potential side effects. The study does not include any measures or tests that would be used to detect adverse events, such as monitoring vital signs or conducting laboratory tests. Furthermore, the sample size is too small to detect rare but potentially serious side effects. Finally, the study does not have a control group, which means that any observed adverse events could be due to other factors and not necessarily related to the drug being tested.

The report finds that the global economy is facing a number of challenges, including rising inequality, slow economic growth, and increasing environmental degradation. It also highlights the need for governments to take action to address these issues. In particular, it calls for increased investment in infrastructure and education, as well as measures to reduce poverty and promote sustainable development. Additionally, the report emphasizes the importance of international cooperation in order to ensure that all countries benefit from global economic growth. Finally, it stresses the need for policies that promote innovation and entrepreneurship in order to create jobs and spur economic growth.

  • “Among non-serious unsolicited adverse events, there was a numerical imbalance of four cases of Bell’s palsy in the vaccine group compared with no cases in the placebo group, though the four cases in the vaccine group do not represent a frequency above that expected in the general population.â€

Therefore, the baseline rate of any adverse event is not a meaningful comparison for the risk associated with the COVID-19 vaccine.

A 10-fold increase of serious adverse events on second dose in older adults on second dose, compared to 3.6-fold for those under 55

It is possible that individuals who experience these symptoms may be at higher risk of serious morbidity and mortality if they become infected with SARS-CoV-2. This is because the body’s immune system may have been primed by the initial infection, making it more susceptible to a secondary infection. This phenomenon, known as pathogenic priming, has been observed in other viral infections such as influenza and HIV. However, further research is needed to determine whether this is the case for SARS-CoV-2.

This suggests that the vaccine may be more effective in older adults than in younger adults. It is possible that the immune system of older adults is more responsive to the vaccine, leading to a greater protective effect against SSAEs. Additionally, it could be that the younger group had fewer SSAEs due to their overall better health and lower risk of developing serious complications from SSAEs. Further research is needed to understand why this difference exists and how it can be addressed.

Animal trials insufficient

Therefore, the human trials did not rule out pathogenic priming in any way.

The world’s top vaccine promoters have been warning us about the unique and frightening dangers inherent in developing a coronavirus vaccine because of the potential for serious side effects, including allergic reactions, autoimmune disorders, and other long-term health complications. Additionally, there is a risk that the virus could mutate and become resistant to the vaccine, rendering it ineffective. Finally, there is also a risk that the vaccine could be ineffective in preventing infection or transmission of the virus.

The video footage shows Offit, Hotez and Fauci warning that any new coronavirus vaccine could trigger lethal immune reactions, known as “vaccine enhancement”. This is a serious concern, as it could mean that vaccinated people would be more susceptible to the wild virus than those who are not vaccinated. The footage also shows Fauci discussing the need to fast track vaccines without conducting critical animal studies before moving into human clinical trials. This decision was made despite the potential risks of such a move, and was partially funded by Gates.

This means that vaccine makers cannot be sued for any adverse events caused by their vaccines.

Gates’ concern is understandable, given the potential for serious side effects from a new vaccine. Vaccines are typically tested in clinical trials before they are approved for use, but there is always a risk of unexpected side effects when a new vaccine is released to the public. By providing immunity from liability, governments are attempting to ensure that vaccine makers will continue to develop and produce vaccines without fear of being sued if something goes wrong. However, this also means that those who suffer from adverse events due to the vaccine have no legal recourse.

Everyone’s risk tolerance is different, so it is important to consider your own personal circumstances and make an informed decision.

1. “The Impact of Social Media on Mental Health: A Systematic Review”
2. “Exploring the Relationship Between Social Media Use and Depression in Adolescents”
3. “The Role of Social Media in Promoting Positive Mental Health Outcomes”

This Emergency Declaration is made pursuant to the laws of [State], and is effective immediately.

I, [Name], hereby declare a state of emergency in [Location] due to [Reason]. This declaration shall remain in effect until further notice.

During this period of emergency, I hereby authorize the following actions:
[List Actions]

Furthermore, I hereby direct all relevant government agencies and personnel to take any necessary steps to ensure the safety and well-being of the citizens of [Location].

This declaration is effective immediately.

Done this [Date] day of [Month], [Year].


1. “How to Create a Balanced Diet”
2. “The Benefits of Eating Healthy Foods”
3. “Understanding Macronutrients and Micronutrients”
4. “Tips for Eating More Nutritious Meals”
5. “The Role of Exercise in Maintaining a Healthy Lifestyle”

Copyright © 2021 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

Children’s Health Defense (CHD) is a non-profit organization dedicated to protecting children from environmental health hazards and eliminating harmful exposures. CHD works to ensure that all children have access to safe, healthy environments and the opportunity to reach their full potential. Through research, education, advocacy, and legal action, CHD seeks to protect children from toxic chemicals, heavy metals, radiation, and other environmental health threats. CHD also works to promote policies that protect children’s health and safety.

The most important thing to remember when writing a persuasive essay is to make sure that the argument is well-supported with evidence. This means that the writer should provide facts, statistics, and other forms of evidence to back up their claims. Additionally, it is important to make sure that the essay is organized in a logical manner and that all points are clearly stated and explained. Finally, it is important to use language that is persuasive and convincing in order to effectively persuade the reader.

The best way to learn a new language is to immerse yourself in it. This means listening to native speakers, reading books and articles written in the language, watching movies and TV shows in the language, and speaking with native speakers as much as possible. Additionally, taking classes or using online resources can help you learn the basics of grammar and vocabulary. Finally, practice makes perfect – so make sure to practice your new language every day!